UW Health, Madison, WI
Matthew Folstad , Arun Augustine , Fauzia Hollnagel , Cibele Carroll , Ashleigh Saner , Jeff Pier , Michael Lavitschke , Peter Kleinschmidt , Heidi Twedt , Amye Juliet Tevaarwerk , Hamid Emamekhoo
Background: To improve documentation quality in Medical Onc outpatient clinics, a standardized template was created. In this template we embedded: 1. An Epic SmartForm to collect structured data (SD) about patient, disease, and response status at each encounter. Minimal Common Oncology Data Elements (mCODE) compatible SD elements were used to enhance interoperability. 2. Several clinically impactful quality metrics (QM) selected based on the Quality Onc Practice Initiative (QOPI) guidelines. In this analysis, we aim to assess how template use impacted documentation quality. Methods: 113,376 outpatient encounters occurred between 01/2018 – 12/2022 (41 providers: 35 physicians, 6 APPs). The template go live was 3/19/2019. 2,520 randomly selected encounters were manually reviewed. Distinct documentation of 8 items served as QMs (Table). Of note, using the template was voluntary and data entry in the embedded form is not mandated. Documentation of each QM was compared between notes authored with/without template. For each note, a completeness score was calculated based on total number of QMs present/note. Categorical comparisons were made using chi-squared or Fisher’s exact tests. Numerical/continuous values were summarized using means and standard deviations. A template “user” was defined as a provider using the template in >10% of encounters after go live. This QI project was exempted by IRB. Results: 154/2520 encounters were excluded after manual review (visits not for solid tumor malignancy). The template was used in 38.7% (917/2366) of the reviewed notes. Cancer diagnosis was documented in >99.8% of notes regardless of template use. Template use was associated with increased documentation of 7 QMs (Table). Documentation overall completeness improved from 62% to 90% with a very large effect size (Table). Template use positively correlated with female gender and fewer years since last training (p<0.001). In the subgroup of notes written by “users” (21 physicians, 4 APPs), individual QM and overall completeness scores improved with template use (p<0.001). Conclusions: Template use profoundly improved QM documentation (statistically significant and clinically meaningful) by Onc clinic providers. This strategy enhances mCODE compatible structured data collection and semantic interoperability between systems, strengthening the available real-world data (RWD) in EHR.
Quality Measures | Template Not Used N = 1449 %, mean (SD) | Template Used N = 917 %, mean (SD) | P- Value |
---|---|---|---|
Cancer Diagnosis | 100 (4) | 100 (3) | 0.571 |
Cancer Stage | 62 (48) | 98 (15) | * |
Treatment plan | 96 (20) | 100 (5) | * |
Treatment Phase | 26 (44) | 92 (26) | * |
Treatment Intent | 41 (49) | 95 (22) | * |
Response to treatment | 75 (43) | 88 (33) | * |
Presence of metastatic disease | 72 (45) | 83 (37) | * |
Performance Status | 62 (48) | 90 (30) | * |
Overall completeness | 62 (17) | 90 (16) | * |
*<0.001 (Statistically significant at p≤0.05)
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2023 ASCO Quality Care Symposium
First Author: Anthony DiDonato
2024 ASCO Annual Meeting
First Author: Divya Deepak
2023 ASCO Annual Meeting
First Author: Arash Maghsoudi
2022 ASCO Quality Care Symposium
First Author: Christine Bates